235 related articles for article (PubMed ID: 30729761)
1. The role of MR volumetry in brain atrophy assessment in multiple sclerosis: A review of the literature.
Marciniewicz E; Podgórski P; Sąsiadek M; Bladowska J
Adv Clin Exp Med; 2019 Jul; 28(7):989-999. PubMed ID: 30729761
[TBL] [Abstract][Full Text] [Related]
2. Central Atrophy Early in Multiple Sclerosis: Third Ventricle Volumetry versus Planimetry.
Lutz T; Bellenberg B; Schneider R; Weiler F; Köster O; Lukas C
J Neuroimaging; 2017 May; 27(3):348-354. PubMed ID: 27897360
[TBL] [Abstract][Full Text] [Related]
3. Brain Atrophy in Multiple Sclerosis: Clinical Relevance and Technical Aspects.
Sastre-Garriga J; Pareto D; Rovira À
Neuroimaging Clin N Am; 2017 May; 27(2):289-300. PubMed ID: 28391787
[TBL] [Abstract][Full Text] [Related]
4. A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study.
Uher T; Krasensky J; Vaneckova M; Sobisek L; Seidl Z; Havrdova E; Bergsland N; Dwyer MG; Horakova D; Zivadinov R
J Neuroimaging; 2017 Nov; 27(6):620-629. PubMed ID: 28464417
[TBL] [Abstract][Full Text] [Related]
5. Imaging Mechanisms of Disease Progression in Multiple Sclerosis: Beyond Brain Atrophy.
Bagnato F; Gauthier SA; Laule C; Moore GRW; Bove R; Cai Z; Cohen-Adad J; Harrison DM; Klawiter EC; Morrow SA; Öz G; Rooney WD; Smith SA; Calabresi PA; Henry RG; Oh J; Ontaneda D; Pelletier D; Reich DS; Shinohara RT; Sicotte NL;
J Neuroimaging; 2020 May; 30(3):251-266. PubMed ID: 32418324
[TBL] [Abstract][Full Text] [Related]
6. Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach.
Uher T; Vaneckova M; Sormani MP; Krasensky J; Sobisek L; Dusankova JB; Seidl Z; Havrdova E; Kalincik T; Benedict RH; Horakova D
Eur J Neurol; 2017 Feb; 24(2):292-301. PubMed ID: 27873386
[TBL] [Abstract][Full Text] [Related]
7. Characterizing Clinical and MRI Dissociation in Patients with Multiple Sclerosis.
Healy BC; Buckle GJ; Ali EN; Egorova S; Khalid F; Tauhid S; Glanz BI; Chitnis T; Guttmann CRG; Weiner HL; Bakshi R
J Neuroimaging; 2017 Sep; 27(5):481-485. PubMed ID: 28261936
[TBL] [Abstract][Full Text] [Related]
8. Measuring brain atrophy in multiple sclerosis.
De Stefano N; Battaglini M; Smith SM
J Neuroimaging; 2007 Apr; 17 Suppl 1():10S-15S. PubMed ID: 17425728
[TBL] [Abstract][Full Text] [Related]
9. The Role of High-Frequency MRI Monitoring in the Detection of Brain Atrophy in Multiple Sclerosis.
Uher T; Krasensky J; Sobisek L; Seidl Z; Bergsland N; Dwyer MG; Kubala Havrdova E; Zivadinov R; Horakova D; Vaneckova M
J Neuroimaging; 2018 May; 28(3):328-337. PubMed ID: 29485230
[TBL] [Abstract][Full Text] [Related]
10. Brain MRI atrophy quantification in MS: From methods to clinical application.
Rocca MA; Battaglini M; Benedict RH; De Stefano N; Geurts JJ; Henry RG; Horsfield MA; Jenkinson M; Pagani E; Filippi M
Neurology; 2017 Jan; 88(4):403-413. PubMed ID: 27986875
[TBL] [Abstract][Full Text] [Related]
11. Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging.
Storelli L; Rocca MA; Pagani E; Van Hecke W; Horsfield MA; De Stefano N; Rovira A; Sastre-Garriga J; Palace J; Sima D; Smeets D; Filippi M;
Radiology; 2018 Aug; 288(2):554-564. PubMed ID: 29714673
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis.
Mellergård J; Tisell A; Blystad I; Grönqvist A; Blennow K; Olsson B; Dahle C; Vrethem M; Lundberg P; Ernerudh J
Eur J Neurol; 2017 Jan; 24(1):112-121. PubMed ID: 27699930
[TBL] [Abstract][Full Text] [Related]
13. Recommendations of the Polish Medical Society of Radiology and the Polish Society of Neurology for a protocol concerning routinely used magnetic resonance imaging in patients with multiple sclerosis.
Sąsiadek M; Hartel M; Siger M; Katulska K; Majos A; Kluczewska E; Bartosik-Psujek H; Kułakowska A; Słowik A; Steinborn B; Adamczyk-Sowa M; Kalinowska A; Krzystanek E; Bonek R; Serafin Z; Sławek J; Nowacki P; Stępień A; Jóżwiak S; Rejdak K; Selmaj K; Walecki J
Neurol Neurochir Pol; 2020; 54(5):410-415. PubMed ID: 33085075
[TBL] [Abstract][Full Text] [Related]
14. Brain atrophy assessment in multiple sclerosis: importance and limitations.
Giorgio A; Battaglini M; Smith SM; De Stefano N
Neuroimaging Clin N Am; 2008 Nov; 18(4):675-86, xi. PubMed ID: 19068408
[TBL] [Abstract][Full Text] [Related]
15. Intercontinental validation of brain volume measurements using MSmetrix.
Finkelsztejn A; Fragoso YD; Bastos EA; Duarte JA; Varela JS; Houbrechts R; Sima D; Van Hecke W
Neuroradiol J; 2018 Apr; 31(2):147-149. PubMed ID: 28730868
[TBL] [Abstract][Full Text] [Related]
16. Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
Chu R; Tauhid S; Glanz BI; Healy BC; Kim G; Oommen VV; Khalid F; Neema M; Bakshi R
J Neuroimaging; 2016; 26(1):62-7. PubMed ID: 26118637
[TBL] [Abstract][Full Text] [Related]
17. Spinal cord atrophy in anterior-posterior direction reflects impairment in multiple sclerosis.
Lundell H; Svolgaard O; Dogonowski AM; Romme Christensen J; Selleberg F; Soelberg Sørensen P; Blinkenberg M; Siebner HR; Garde E
Acta Neurol Scand; 2017 Oct; 136(4):330-337. PubMed ID: 28070886
[TBL] [Abstract][Full Text] [Related]
18. Salient Central Lesion Volume: A Standardized Novel Fully Automated Proxy for Brain FLAIR Lesion Volume in Multiple Sclerosis.
Dwyer MG; Bergsland N; Ramasamy DP; Weinstock-Guttman B; Barnett MH; Wang C; Tomic D; Silva D; Zivadinov R
J Neuroimaging; 2019 Sep; 29(5):615-623. PubMed ID: 31259467
[TBL] [Abstract][Full Text] [Related]
19. Whole-brain atrophy: ready for implementation into clinical decision-making in multiple sclerosis?
Azevedo CJ; Pelletier D
Curr Opin Neurol; 2016 Jun; 29(3):237-42. PubMed ID: 27070219
[TBL] [Abstract][Full Text] [Related]
20. A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis.
Yousuf F; Dupuy SL; Tauhid S; Chu R; Kim G; Tummala S; Khalid F; Weiner HL; Chitnis T; Healy BC; Bakshi R
J Neurol Sci; 2017 Dec; 383():221-229. PubMed ID: 29146095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
